Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech Aktie: Aus für US-Impfstudie

TorstenPinkert 
0 0 02.04.26
BioNTech Aktie: Aus für US-ImpfstudiePhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
 

Pfizer und BioNTech ziehen bei einer groß angelegten US-Studie für ihren angepassten Corona-Impfstoff die…

Der Beitrag BioNTech Aktie: Aus für US-Impfstudie erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

Pfizer Inc. Stock

€23.52
1.360%
Pfizer Inc. gained 1.360% today.
We see a rather positive sentiment for Pfizer Inc. with 15 Buy predictions and 2 Sell predictions.
As a result the target price of 29 € shows a positive potential of 23.3% compared to the current price of 23.52 € for Pfizer Inc..
Show more
Like: 0
Analystenstimmen
Share

Comments

Not a member yet? Sign up for free!